In this Issue
Understanding the effect of corticosteroid pretreatment in brain-dead organ donors: new mechanistic insights for improvement of organ quality in liver transplantation
Clinical Science (15 September 2017) 131 (18): 2377–2379.
Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model
Hao Wang; Desiree Anthony; Selcuk Yatmaz; Odilia Wijburg; Catherine Satzke; Bruce Levy; Ross Vlahos; Steven Bozinovski
Clinical Science (15 September 2017) 131 (18): 2347–2362.
Circulating miR-200c is up-regulated in paediatric patients with familial hypercholesterolaemia and correlates with miR-33a/b levels: implication of a ZEB1-dependent mechanism
Marco D’Agostino; Francesco Martino; Sara Sileno; Francesco Barillà; Sara Beji; Lorenza Marchetti; Fabio Maria Gangi; Luca Persico; Mario Picozza; Anna Montali; Eliana Martino; Cristina Zanoni; Daniele Avitabile; Sandro Parrotto; Maurizio Colognesi Capogrossi; Alessandra Magenta
Clinical Science (15 September 2017) 131 (18): 2397–2408.
Cover ImageA flurogold labeled-retina flatmount (front) representing surviving retinal ganglion cells, and the chemical structure of trimetazidine (background). In Clinical Science volume 131, issue 18, Wan et al. report that trimetazidine protects retinal ganglion cells against acute glaucoma via the Nrf2/Ho-1 pathway and propose it as a novel therapeutic agent; for details, see pages 2363-2375.